RecallRadar

FDA Drug recall D-1029-2020

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengalu…

On 2020-03-25 the FDA classified a Class III recall of Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengalu… by Strides Pharma Science, citing failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1029-2020
ClassificationClass III
Statusterminated
Initiated2020-02-17
Published2020-03-25
Last updated2026-09-13 11:52 UTC
CompanyStrides Pharma Science
DistributionUS

Product

Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only, Manufactured by: Strides Shasun Limited Bengaluru - 562106, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816, NDC 64380-861-08

Reason

Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.

Identifiers

ndc64380-860-06
ndc64380-860-07
ndc64380-860-08
ndc64380-861-06
ndc64380-861-07
ndc64380-861-08
code_infoLot #: 7238958A, 7238257A, Exp 7/31/2021; 7239404A, Exp 9/30/2021

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1029-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.